JAK2 and Hodgkins lymphoma: HL and PMBL thus exhibit higher JAK2 transcript levels with increased JAK2 activity [25], suggesting aberrant activity of JAK2 and STAT pathways may in part play an important role in the pathogenesis and/or resistance in AYA HL and PMBL.